| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,266 |
2,985 |
$132K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,455 |
7,941 |
$124K |
| 80061 |
Lipid panel |
9,375 |
8,832 |
$116K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,825 |
3,586 |
$101K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,239 |
13,097 |
$97K |
| 80053 |
Comprehensive metabolic panel |
8,762 |
8,186 |
$81K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,770 |
2,549 |
$65K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,314 |
4,974 |
$47K |
| 82274 |
|
2,574 |
2,404 |
$38K |
| 81000 |
|
11,384 |
10,630 |
$33K |
| 82607 |
|
1,806 |
1,679 |
$25K |
| 84153 |
|
1,279 |
1,201 |
$22K |
| 36415 |
Collection of venous blood by venipuncture |
9,760 |
8,946 |
$21K |
| 86738 |
|
1,559 |
1,456 |
$20K |
| 82043 |
|
3,415 |
3,169 |
$19K |
| 87276 |
|
1,064 |
987 |
$14K |
| 87088 |
|
1,769 |
1,661 |
$13K |
| 84479 |
|
2,291 |
2,183 |
$13K |
| 84436 |
|
2,135 |
2,044 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
259 |
256 |
$13K |
| 87275 |
|
1,048 |
971 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,486 |
1,382 |
$12K |
| 84439 |
|
1,085 |
970 |
$10K |
| 86701 |
|
1,036 |
1,002 |
$9K |
| 82565 |
|
1,241 |
1,164 |
$5K |
| 80050 |
General health panel |
444 |
442 |
$4K |
| 86328 |
|
164 |
160 |
$4K |
| 82947 |
|
1,145 |
1,086 |
$4K |
| 80074 |
|
80 |
76 |
$4K |
| 87400 |
|
365 |
346 |
$4K |
| 84520 |
|
1,063 |
1,014 |
$4K |
| 86592 |
|
799 |
746 |
$3K |
| 82746 |
|
270 |
247 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
94 |
93 |
$3K |
| 85651 |
|
748 |
705 |
$2K |
| 82570 |
|
422 |
363 |
$2K |
| 86803 |
|
140 |
138 |
$2K |
| 83970 |
|
46 |
42 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
37 |
37 |
$1K |
| 86769 |
|
29 |
28 |
$1K |
| 85730 |
|
158 |
149 |
$841.61 |
| 85610 |
|
211 |
197 |
$731.79 |
| 82728 |
|
58 |
52 |
$685.64 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
13 |
13 |
$667.29 |
| 86631 |
|
39 |
39 |
$517.45 |
| 86140 |
|
85 |
80 |
$371.83 |
| 86038 |
|
29 |
29 |
$316.87 |
| 83655 |
|
19 |
12 |
$250.61 |
| 82378 |
|
14 |
14 |
$249.82 |
| 84156 |
|
55 |
50 |
$192.46 |
| 83540 |
|
13 |
13 |
$80.19 |
| 82950 |
|
15 |
12 |
$58.09 |
| 82270 |
|
16 |
14 |
$45.30 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
837 |
742 |
$0.00 |